| 产品详情 |
| Edit |   |
|---|
| Product Name | Trazodone-d6 |
|---|
| Description | Trazodone was originally discovered and developed in Italy in the 1960s by Angelini research laboratories as a second-generation antidepressant. It was developed according to the mental pain hypothesis, which was postulated from studying patients and which proposes that major depression is associated with a decreased pain threshold. Trazodone also has anxiolytic, and hypnotic effects (1). Trazodone was patented and marketed in many countries all over the world. It was approved by the Food and Drug Administration (FDA) at the end of 1981. |
|---|
| Size | 1mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Trazodone-d6 (2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl-d6]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | T8268 |
|---|
| Price | |
|---|
| Order / More Info | Trazodone-d6 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|